Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Metformin 1000mg (S.R.) Tablets
Therapeutic Category
Antidiabetic, Diabetic
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*15
Price
₹63/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Metfoam 1000 SR is a sustained release formulation of Metformin 1000mg, widely prescribed for the management of Type 2 Diabetes Mellitus. It helps in reducing elevated blood glucose levels by decreasing hepatic glucose production and improving insulin sensitivity. The SR formulation ensures gradual drug release, improving gastrointestinal tolerance and allowing for once-daily dosing. It supports better glycemic control and may aid in weight stabilization, especially in overweight diabetic individuals.
Patients may experience mild side effects such as nausea, bloating, or abdominal discomfort during initial use. Rarely, serious effects like lactic acidosis can occur, particularly in individuals with kidney problems or those taking excessive alcohol.
Metfoam 1000 SR is indicated for adults with Type 2 Diabetes Mellitus, particularly when lifestyle interventions such as diet and exercise do not provide adequate control of blood sugar levels.
Not advised for use in patients with significant renal or hepatic dysfunction. Alcohol intake should be limited. Regular kidney function tests are recommended during prolonged use.
Store Metfoam 1000 SR tablets in a cool, dry environment below 25°C. Protect from light and moisture. Keep out of reach of children.
Composition : Sitagliptin Phosphate I.P. 50mg + Metformin HCL I.P. 500mg Tablets
Composition : Sitagliptin Phosphate I.P. 100mg + Dapagliflozin Propanediol U.S.P. 10mg Tablets
Composition : Sitagliptin Phosphate I.P. 50mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg Tablets
Composition : Atorvastatin Calcium I.P. 20mg Tablets
Composition : Atorvastatin Calcium I.P. 40mg Tablets
Composition : Atorvastatin Calcium I.P. 80mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Aspirin I.P. 75mg Capsules
Composition : Atorvastatin Calcium I.P. 10mg + Clopidogrel I.P. 75mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Fenofibrate I.P. 160mg Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Metformin 1000mg S.R. (Sustained Release) Tablet has strong demand in the diabetes management and endocrinology segment, making it a core product for medical distributors, wholesalers, and pharma franchise partners focusing on chronic care and anti-diabetic portfolios.
Medical distributors and agencies can benefit from consistent and long-term demand for Type 2 diabetes management under medical supervision. Metformin is a first-line oral anti-diabetic medicine S.R. (Sustained Release) formulation provides better tolerance and once-daily dosing convenience Commonly prescribed for Type 2 diabetes mellitus and insulin resistance management Widely used in long-term chronic therapy, ensuring regular repeat prescriptions This strengthens a high-demand chronic care and diabetic portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Metformin 1000mg S.R. Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from high prescription volume in diabetes care, long-term repeat sales, stable demand throughout the year, reliable supply chain support, and attractive margins in the anti-diabetic segment.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality products, and a dependable supply chain to grow their pharmaceutical business successfully.